Kevin Bitterman

Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.

Chroma Medicine is a new genomic medicine company working on epigenetic editing.

Raised $260,000,000.00 from Newpath Management, Atlas Venture, Mubadala Capital Ventures, DCVC Bio, Wellington Management, Janus Henderson Investors, Alexandria Venture Investments, Omega Funds, Sixth Street and ARCH Venture Partners.

Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.

Raised $211,000,000.00 from Surveyor Capital, The Column Group, Atlas Venture, Alexandria Venture Investments, Casdin Capital, ARCH Venture Partners, Foresite Capital, WTT Investment and Willett Advisors LLC.

Mariana Oncology is a biotechnology research industry.

Raised $250,000,000.00 from RA Capital Management, Nextech Invest, Surveyor Capital, Atlas Ventures, Forbion Capital Partners, Deep Track Capital, Eli Lilly and Access Biotechnology.

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.

Raised $41,500,000.00 from Gimv, Atlas Venture and 5AM Ventures.

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Raised $792,800,000.00 from Hercules Capital.

Isabella Stewart Gardner Museum showcases a remarkable art collection along with immersive galleries and a flower-filled courtyard.

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

Raised $951,100,000.00 from Hercules Capital.

Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.

Raised $98,168,747.00 from SR One, Sanofi Ventures, Remeditex Ventures, Atlas Venture, Polaris Partners, Brace Pharma and Johnson & Johnson Robotics and Digital Solutions.